
Ceribell Inc (CBLL) Stock Forecast & Price Target
Ceribell Inc (CBLL) Analyst Ratings
Bulls say
CeriBell Inc. is poised for substantial growth, projecting revenues of $87M-$89M in 2025, reflecting a year-over-year increase of 33%-36%, driven by strategic investments in its salesforce and expanded market presence. The company is focusing on increasing account penetration, particularly in VA hospitals and new demographics, which positions it well for continued commercial traction and operational leverage. With gross margins nearing optimization in the mid-80% range and a dual-stream revenue model, CeriBell is well-equipped to achieve cash-flow breakeven while pursuing long-term profitability through innovative pipeline initiatives.
Bears say
CeriBell Inc. is currently not generating free cash flow and reported a substantial net loss of $40 million in the latest fiscal year, highlighting the company's financial instability. The company faces additional margin pressures due to tariffs and legal expenses, which could further decrease its gross margins amid potential increases in import tariffs or supply chain disruptions. Furthermore, CeriBell operates with a low market capitalization and a history of operating losses, compounded by a relatively low penetration rate of 25-30% within its existing accounts, indicating challenges in sustaining growth in a competitive environment.
This aggregate rating is based on analysts' research of Ceribell Inc and is not a guaranteed prediction by Public.com or investment advice.
Ceribell Inc (CBLL) Analyst Forecast & Price Prediction
Start investing in Ceribell Inc (CBLL)
Order type
Buy in
Order amount
Est. shares
0 shares